Validation of Malay brief screening instrument for ascertainment of epilepsy

Si Lei Fong, Kheng Seang Lim, Lee Ann Tan, Tahir Aris, Raihanah Abd Khalid, Raymond Azman Ali, Mashkur Muhamad, Santhi Datuk Puvanarajah, Wan Chung Law

Research output: Contribution to journalArticle

Abstract

Introduction: Prevalence studies of epilepsy in Asia revealed a prevalence ranging from 1.5 to 14.0 per 1000 among Asian populations. However, the prevalence of epilepsy in Malaysia is not available for comparison with other countries. This study aimed to translate and validate a Malay brief screening instruments for ascertainment of epilepsy. Method: We translated into Malay a brief screening instrument for ascertainment of epilepsy designed and validated by Ottman et al., using the three-stage cross-cultural adaptation process developed by the International Quality of Life Assessment (IQOLA) project. We then administered the translated questionnaire via online survey to 162 cases (patients with epilepsy under follow-up care at the neurology clinic in University of Malaya Medical Centre, Kuala Lumpur) and 146 controls with no known history of epilepsy for validation. Results: Applying the most liberal definition for a positive screen, we obtained a sensitivity of 96.3% (95% confidence interval [CI]: 91.8–98.5%), with a specificity of 66.4% (95% CI: 58.1–73.0%) and positive predictive value (PPV) of 2.0%. The most stringent definition for a positive screen (only epilepsy) resulted in a sensitivity of 97.4% (95% CI: 62.0–72.6%), specificity of 98.6% (95% CI: 94.6–99.7%), and PPV of 26.6%. Narrowing the definition of a positive screen decreased sensitivity but improved PPVs. When compared to the original English questionnaire, the sensitivities were similar for all four definitions of a positive screen. Conclusion: This is the first validated epilepsy screening questionnaire in the Malay language and represents a useful tool for the ascertainment of epilepsy in population-based studies.

Original languageEnglish
Pages (from-to)206-211
Number of pages6
JournalEpilepsy and Behavior
Volume97
DOIs
Publication statusPublished - 1 Aug 2019

Fingerprint

Epilepsy
Confidence Intervals
Malaysia
Aftercare
Neurology
Population
Language
Cross-Sectional Studies
Quality of Life
Surveys and Questionnaires

Keywords

  • Epidemiology
  • Epilepsy
  • Malaysia
  • Questionnaire
  • Screening

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Behavioral Neuroscience

Cite this

Fong, S. L., Lim, K. S., Tan, L. A., Aris, T., Khalid, R. A., Ali, R. A., ... Law, W. C. (2019). Validation of Malay brief screening instrument for ascertainment of epilepsy. Epilepsy and Behavior, 97, 206-211. https://doi.org/10.1016/j.yebeh.2019.05.033

Validation of Malay brief screening instrument for ascertainment of epilepsy. / Fong, Si Lei; Lim, Kheng Seang; Tan, Lee Ann; Aris, Tahir; Khalid, Raihanah Abd; Ali, Raymond Azman; Muhamad, Mashkur; Puvanarajah, Santhi Datuk; Law, Wan Chung.

In: Epilepsy and Behavior, Vol. 97, 01.08.2019, p. 206-211.

Research output: Contribution to journalArticle

Fong, SL, Lim, KS, Tan, LA, Aris, T, Khalid, RA, Ali, RA, Muhamad, M, Puvanarajah, SD & Law, WC 2019, 'Validation of Malay brief screening instrument for ascertainment of epilepsy', Epilepsy and Behavior, vol. 97, pp. 206-211. https://doi.org/10.1016/j.yebeh.2019.05.033
Fong, Si Lei ; Lim, Kheng Seang ; Tan, Lee Ann ; Aris, Tahir ; Khalid, Raihanah Abd ; Ali, Raymond Azman ; Muhamad, Mashkur ; Puvanarajah, Santhi Datuk ; Law, Wan Chung. / Validation of Malay brief screening instrument for ascertainment of epilepsy. In: Epilepsy and Behavior. 2019 ; Vol. 97. pp. 206-211.
@article{6053fba778084c1db04d30653f5f97a3,
title = "Validation of Malay brief screening instrument for ascertainment of epilepsy",
abstract = "Introduction: Prevalence studies of epilepsy in Asia revealed a prevalence ranging from 1.5 to 14.0 per 1000 among Asian populations. However, the prevalence of epilepsy in Malaysia is not available for comparison with other countries. This study aimed to translate and validate a Malay brief screening instruments for ascertainment of epilepsy. Method: We translated into Malay a brief screening instrument for ascertainment of epilepsy designed and validated by Ottman et al., using the three-stage cross-cultural adaptation process developed by the International Quality of Life Assessment (IQOLA) project. We then administered the translated questionnaire via online survey to 162 cases (patients with epilepsy under follow-up care at the neurology clinic in University of Malaya Medical Centre, Kuala Lumpur) and 146 controls with no known history of epilepsy for validation. Results: Applying the most liberal definition for a positive screen, we obtained a sensitivity of 96.3{\%} (95{\%} confidence interval [CI]: 91.8–98.5{\%}), with a specificity of 66.4{\%} (95{\%} CI: 58.1–73.0{\%}) and positive predictive value (PPV) of 2.0{\%}. The most stringent definition for a positive screen (only epilepsy) resulted in a sensitivity of 97.4{\%} (95{\%} CI: 62.0–72.6{\%}), specificity of 98.6{\%} (95{\%} CI: 94.6–99.7{\%}), and PPV of 26.6{\%}. Narrowing the definition of a positive screen decreased sensitivity but improved PPVs. When compared to the original English questionnaire, the sensitivities were similar for all four definitions of a positive screen. Conclusion: This is the first validated epilepsy screening questionnaire in the Malay language and represents a useful tool for the ascertainment of epilepsy in population-based studies.",
keywords = "Epidemiology, Epilepsy, Malaysia, Questionnaire, Screening",
author = "Fong, {Si Lei} and Lim, {Kheng Seang} and Tan, {Lee Ann} and Tahir Aris and Khalid, {Raihanah Abd} and Ali, {Raymond Azman} and Mashkur Muhamad and Puvanarajah, {Santhi Datuk} and Law, {Wan Chung}",
year = "2019",
month = "8",
day = "1",
doi = "10.1016/j.yebeh.2019.05.033",
language = "English",
volume = "97",
pages = "206--211",
journal = "Epilepsy and Behavior",
issn = "1525-5050",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Validation of Malay brief screening instrument for ascertainment of epilepsy

AU - Fong, Si Lei

AU - Lim, Kheng Seang

AU - Tan, Lee Ann

AU - Aris, Tahir

AU - Khalid, Raihanah Abd

AU - Ali, Raymond Azman

AU - Muhamad, Mashkur

AU - Puvanarajah, Santhi Datuk

AU - Law, Wan Chung

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Introduction: Prevalence studies of epilepsy in Asia revealed a prevalence ranging from 1.5 to 14.0 per 1000 among Asian populations. However, the prevalence of epilepsy in Malaysia is not available for comparison with other countries. This study aimed to translate and validate a Malay brief screening instruments for ascertainment of epilepsy. Method: We translated into Malay a brief screening instrument for ascertainment of epilepsy designed and validated by Ottman et al., using the three-stage cross-cultural adaptation process developed by the International Quality of Life Assessment (IQOLA) project. We then administered the translated questionnaire via online survey to 162 cases (patients with epilepsy under follow-up care at the neurology clinic in University of Malaya Medical Centre, Kuala Lumpur) and 146 controls with no known history of epilepsy for validation. Results: Applying the most liberal definition for a positive screen, we obtained a sensitivity of 96.3% (95% confidence interval [CI]: 91.8–98.5%), with a specificity of 66.4% (95% CI: 58.1–73.0%) and positive predictive value (PPV) of 2.0%. The most stringent definition for a positive screen (only epilepsy) resulted in a sensitivity of 97.4% (95% CI: 62.0–72.6%), specificity of 98.6% (95% CI: 94.6–99.7%), and PPV of 26.6%. Narrowing the definition of a positive screen decreased sensitivity but improved PPVs. When compared to the original English questionnaire, the sensitivities were similar for all four definitions of a positive screen. Conclusion: This is the first validated epilepsy screening questionnaire in the Malay language and represents a useful tool for the ascertainment of epilepsy in population-based studies.

AB - Introduction: Prevalence studies of epilepsy in Asia revealed a prevalence ranging from 1.5 to 14.0 per 1000 among Asian populations. However, the prevalence of epilepsy in Malaysia is not available for comparison with other countries. This study aimed to translate and validate a Malay brief screening instruments for ascertainment of epilepsy. Method: We translated into Malay a brief screening instrument for ascertainment of epilepsy designed and validated by Ottman et al., using the three-stage cross-cultural adaptation process developed by the International Quality of Life Assessment (IQOLA) project. We then administered the translated questionnaire via online survey to 162 cases (patients with epilepsy under follow-up care at the neurology clinic in University of Malaya Medical Centre, Kuala Lumpur) and 146 controls with no known history of epilepsy for validation. Results: Applying the most liberal definition for a positive screen, we obtained a sensitivity of 96.3% (95% confidence interval [CI]: 91.8–98.5%), with a specificity of 66.4% (95% CI: 58.1–73.0%) and positive predictive value (PPV) of 2.0%. The most stringent definition for a positive screen (only epilepsy) resulted in a sensitivity of 97.4% (95% CI: 62.0–72.6%), specificity of 98.6% (95% CI: 94.6–99.7%), and PPV of 26.6%. Narrowing the definition of a positive screen decreased sensitivity but improved PPVs. When compared to the original English questionnaire, the sensitivities were similar for all four definitions of a positive screen. Conclusion: This is the first validated epilepsy screening questionnaire in the Malay language and represents a useful tool for the ascertainment of epilepsy in population-based studies.

KW - Epidemiology

KW - Epilepsy

KW - Malaysia

KW - Questionnaire

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=85067809219&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067809219&partnerID=8YFLogxK

U2 - 10.1016/j.yebeh.2019.05.033

DO - 10.1016/j.yebeh.2019.05.033

M3 - Article

VL - 97

SP - 206

EP - 211

JO - Epilepsy and Behavior

JF - Epilepsy and Behavior

SN - 1525-5050

ER -